loading...| Preferred Name |
Hemophilia A |
| ID |
http://www.orpha.net/ORDO/Orphanet_98878 |
| alternative_term |
Congenital Factor VIII deficiency Congenital FVIII deficiency Congenital F8 deficiency |
| definition |
A rare genetic hematological disorder characterized by spontaneous or prolonged hemorrhages due to factor VIII deficiency. |
| definition_citation |
Orphanet |
| expertlink |
https://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=98878 |
| has_age_of_onset |
Childhood Neonatal Infancy |
| has_inheritance |
X-linked recessive |
| hasDbXref |
ICD-10:D66 MeSH:D006467 UMLS:C0019069 OMIM:306700 ICD-11:3B10.0 MedDRA:10016080 |
| label |
Hemophilia A |
| notation |
ORPHA:98878 |
| part_of | |
| prefixIRI |
ORDO:Orphanet_98878 |
| prefLabel |
Hemophilia A |
| present_in |
Sierra leone AND has_point_prevalence_average_value : 0.1 AND has_point_prevalence_range : 1-9 / 1 000 000 Netherlands AND has_point_prevalence_average_value : 9.3 AND has_point_prevalence_range : 1-9 / 100 000 Malaysia AND has_point_prevalence_average_value : 3.3 AND has_point_prevalence_range : 1-9 / 100 000 Belgium AND has_point_prevalence_average_value : 6.0 AND has_point_prevalence_range : 1-9 / 100 000 Colombia AND has_point_prevalence_average_value : 2.6 AND has_point_prevalence_range : 1-9 / 100 000 Tunisia AND has_point_prevalence_average_value : 2.2 AND has_point_prevalence_range : 1-9 / 100 000 Jamaica AND has_point_prevalence_average_value : 3.6 AND has_point_prevalence_range : 1-9 / 100 000 Serbia AND has_point_prevalence_average_value : 3.7 AND has_point_prevalence_range : 1-9 / 100 000 El Salvador AND has_point_prevalence_average_value : 3.0 AND has_point_prevalence_range : 1-9 / 100 000 Austria AND has_point_prevalence_average_value : 4.3 AND has_point_prevalence_range : 1-9 / 100 000 Czech Republic AND has_point_prevalence_average_value : 6.1 AND has_point_prevalence_range : 1-9 / 100 000 Australia AND has_point_prevalence_average_value : 6.8 AND has_point_prevalence_range : 1-9 / 100 000 Germany AND has_point_prevalence_average_value : 5.0 AND has_point_prevalence_range : 1-9 / 100 000 South Africa AND has_point_prevalence_average_value : 3.0 AND has_point_prevalence_range : 1-9 / 100 000 China AND has_point_prevalence_average_value : 0.2 AND has_point_prevalence_range : 1-9 / 1 000 000 Spain AND has_point_prevalence_average_value : 3.8 AND has_point_prevalence_range : 1-9 / 100 000 Singapore AND has_point_prevalence_average_value : 4.0 AND has_point_prevalence_range : 1-9 / 100 000 Iran, Islamic Republic of AND has_point_prevalence_average_value : 5.6 AND has_point_prevalence_range : 1-9 / 100 000 Paraguay AND has_point_prevalence_average_value : 1.2 AND has_point_prevalence_range : 1-9 / 100 000 Portugal AND has_point_prevalence_average_value : 4.9 AND has_point_prevalence_range : 1-9 / 100 000 Jordan AND has_point_prevalence_average_value : 3.5 AND has_point_prevalence_range : 1-9 / 100 000 Canada AND has_point_prevalence_average_value : 7.3 AND has_point_prevalence_range : 1-9 / 100 000 Ecuador AND has_point_prevalence_average_value : 2.5 AND has_point_prevalence_range : 1-9 / 100 000 Peru AND has_point_prevalence_average_value : 1.6 AND has_point_prevalence_range : 1-9 / 100 000 Guatemala AND has_point_prevalence_average_value : 1.0 AND has_point_prevalence_range : 1-9 / 100 000 Estonia AND has_point_prevalence_average_value : 2.8 AND has_point_prevalence_range : 1-9 / 100 000 Lithuania AND has_point_prevalence_average_value : 4.1 AND has_point_prevalence_range : 1-9 / 100 000 Bosnia and Herzegovina AND has_point_prevalence_average_value : 2.6 AND has_point_prevalence_range : 1-9 / 100 000 Dominican Republic AND has_point_prevalence_average_value : 1.8 AND has_point_prevalence_range : 1-9 / 100 000 Honduras AND has_point_prevalence_average_value : 2.6 AND has_point_prevalence_range : 1-9 / 100 000 Albania AND has_point_prevalence_average_value : 7.6 AND has_point_prevalence_range : 1-9 / 100 000 Bulgaria AND has_point_prevalence_average_value : 6.8 AND has_point_prevalence_range : 1-9 / 100 000 Belarus AND has_point_prevalence_average_value : 5.1 AND has_point_prevalence_range : 1-9 / 100 000 Malta AND has_point_prevalence_average_value : 3.3 AND has_point_prevalence_range : 1-9 / 100 000 Panama AND has_point_prevalence_average_value : 6.6 AND has_point_prevalence_range : 1-9 / 100 000 Qatar AND has_point_prevalence_average_value : 7.9 AND has_point_prevalence_range : 1-9 / 100 000 Worldwide AND has_birth_prevalence_average_value : 11.25 AND has_birth_prevalence_range : 1-5 / 10 000 Argentina AND has_point_prevalence_average_value : 4.5 AND has_point_prevalence_range : 1-9 / 100 000 United States AND has_point_prevalence_average_value : 7.0 AND has_point_prevalence_range : 1-9 / 100 000 Norway AND has_point_prevalence_average_value : 6.1 AND has_point_prevalence_range : 1-9 / 100 000 India AND has_point_prevalence_average_value : 0.7 AND has_point_prevalence_range : 1-9 / 1 000 000 New Zealand AND has_point_prevalence_average_value : 11.0 AND has_point_prevalence_range : 1-5 / 10 000 Sweden AND has_point_prevalence_average_value : 7.7 AND has_point_prevalence_range : 1-9 / 100 000 Japan AND has_point_prevalence_average_value : 3.3 AND has_point_prevalence_range : 1-9 / 100 000 Nigeria AND has_point_prevalence_average_value : 0.025 AND has_point_prevalence_range : <1 / 1 000 000 Sri Lanka AND has_point_prevalence_average_value : 0.6 AND has_point_prevalence_range : 1-9 / 1 000 000 Mongolia AND has_point_prevalence_average_value : 1.4 AND has_point_prevalence_range : 1-9 / 100 000 North Macedonia AND has_point_prevalence_average_value : 8.1 AND has_point_prevalence_range : 1-9 / 100 000 United Kingdom AND has_point_prevalence_average_value : 10.4 AND has_point_prevalence_range : 1-5 / 10 000 Worldwide AND has_point_prevalence_average_value : 4.85 AND has_point_prevalence_range : 1-9 / 100 000 Egypt AND has_point_prevalence_average_value : 4.4 AND has_point_prevalence_range : 1-9 / 100 000 Iraq AND has_point_prevalence_average_value : 1.8 AND has_point_prevalence_range : 1-9 / 100 000 Israel AND has_point_prevalence_average_value : 5.4 AND has_point_prevalence_range : 1-9 / 100 000 Armenia AND has_point_prevalence_average_value : 5.0 AND has_point_prevalence_range : 1-9 / 100 000 Mexico AND has_point_prevalence_average_value : 2.2 AND has_point_prevalence_range : 1-9 / 100 000 Slovakia AND has_point_prevalence_average_value : 8.6 AND has_point_prevalence_range : 1-9 / 100 000 Azerbaijan AND has_point_prevalence_average_value : 8.0 AND has_point_prevalence_range : 1-9 / 100 000 Algeria AND has_point_prevalence_average_value : 2.8 AND has_point_prevalence_range : 1-9 / 100 000 Philippines AND has_point_prevalence_average_value : 0.9 AND has_point_prevalence_range : 1-9 / 1 000 000 Zimbabwe AND has_point_prevalence_average_value : 2.3 AND has_point_prevalence_range : 1-9 / 100 000 Ireland AND has_point_prevalence_average_value : 9.2 AND has_point_prevalence_range : 1-9 / 100 000 Senegal AND has_point_prevalence_average_value : 0.8 AND has_point_prevalence_range : 1-9 / 1 000 000 Eritrea AND has_point_prevalence_average_value : 0.7 AND has_point_prevalence_range : 1-9 / 1 000 000 Bolivia AND has_point_prevalence_average_value : 0.1 AND has_point_prevalence_range : 1-9 / 1 000 000 Iceland AND has_point_prevalence_average_value : 19.3 AND has_point_prevalence_range : 1-5 / 10 000 Poland AND has_point_prevalence_average_value : 5.6 AND has_point_prevalence_range : 1-9 / 100 000 Costa rica AND has_point_prevalence_average_value : 3.0 AND has_point_prevalence_range : 1-9 / 100 000 Nepal AND has_point_prevalence_average_value : 0.6 AND has_point_prevalence_range : 1-9 / 1 000 000 Viet Nam AND has_point_prevalence_average_value : 1.0 AND has_point_prevalence_range : 1-9 / 100 000 Turkey AND has_point_prevalence_average_value : 3.1 AND has_point_prevalence_range : 1-9 / 100 000 Switzerland AND has_point_prevalence_average_value : 7.1 AND has_point_prevalence_range : 1-9 / 100 000 Georgia AND has_point_prevalence_average_value : 4.4 AND has_point_prevalence_range : 1-9 / 100 000 Lebanon AND has_point_prevalence_average_value : 1.5 AND has_point_prevalence_range : 1-9 / 100 000 Korea, Republic of AND has_point_prevalence_average_value : 3.0 AND has_point_prevalence_range : 1-9 / 100 000 Lesotho AND has_point_prevalence_average_value : 0.7 AND has_point_prevalence_range : 1-9 / 1 000 000 Luxembourg AND has_point_prevalence_average_value : 5.4 AND has_point_prevalence_range : 1-9 / 100 000 Pakistan AND has_point_prevalence_average_value : 0.8 AND has_point_prevalence_range : 1-9 / 1 000 000 Uzbekistan AND has_point_prevalence_average_value : 3.8 AND has_point_prevalence_range : 1-9 / 100 000 Uruguay AND has_point_prevalence_average_value : 4.9 AND has_point_prevalence_range : 1-9 / 100 000 Saudi Arabia AND has_point_prevalence_average_value : 0.5 AND has_point_prevalence_range : 1-9 / 1 000 000 Cyprus AND has_point_prevalence_average_value : 5.2 AND has_point_prevalence_range : 1-9 / 100 000 Belize AND has_point_prevalence_average_value : 2.2 AND has_point_prevalence_range : 1-9 / 100 000 Denmark AND has_point_prevalence_average_value : 6.2 AND has_point_prevalence_range : 1-9 / 100 000 Sudan AND has_point_prevalence_average_value : 0.85 AND has_point_prevalence_range : 1-9 / 1 000 000 France AND has_point_prevalence_average_value : 10.5 AND has_point_prevalence_range : 1-5 / 10 000 Finland AND has_point_prevalence_average_value : 4.6 AND has_point_prevalence_range : 1-9 / 100 000 Nicaragua AND has_point_prevalence_average_value : 3.7 AND has_point_prevalence_range : 1-9 / 100 000 Morocco AND has_point_prevalence_average_value : 1.0 AND has_point_prevalence_range : 1-9 / 100 000 Greece AND has_point_prevalence_average_value : 6.5 AND has_point_prevalence_range : 1-9 / 100 000 Moldova, Republic of AND has_point_prevalence_average_value : 4.7 AND has_point_prevalence_range : 1-9 / 100 000 Europe AND has_point_prevalence_average_value : 8.0 AND has_point_prevalence_range : 1-9 / 100 000 Chile AND has_point_prevalence_average_value : 5.3 AND has_point_prevalence_range : 1-9 / 100 000 Togo AND has_point_prevalence_average_value : 0.02 AND has_point_prevalence_range : <1 / 1 000 000 Cuba AND has_point_prevalence_average_value : 2.7 AND has_point_prevalence_range : 1-9 / 100 000 Indonesia AND has_point_prevalence_average_value : 0.1 AND has_point_prevalence_range : 1-9 / 1 000 000 Palestinian Territory, occupied AND has_point_prevalence_average_value : 2.7 AND has_point_prevalence_range : 1-9 / 100 000 Russian Federation AND has_point_prevalence_average_value : 3.3 AND has_point_prevalence_range : 1-9 / 100 000 Brazil AND has_point_prevalence_average_value : 3.7 AND has_point_prevalence_range : 1-9 / 100 000 Italy AND has_point_prevalence_average_value : 4.7 AND has_point_prevalence_range : 1-9 / 100 000 Africa AND has_point_prevalence_average_value : 1.58 AND has_point_prevalence_range : 1-9 / 100 000 Venezuela AND has_point_prevalence_average_value : 4.9 AND has_point_prevalence_range : 1-9 / 100 000 Croatia AND has_point_prevalence_average_value : 8.5 AND has_point_prevalence_range : 1-9 / 100 000 Thailand AND has_point_prevalence_average_value : 1.8 AND has_point_prevalence_range : 1-9 / 100 000 Hungary AND has_point_prevalence_average_value : 8.3 AND has_point_prevalence_range : 1-9 / 100 000 Bangladesh AND has_point_prevalence_average_value : 0.2 AND has_point_prevalence_range : 1-9 / 1 000 000 Romania AND has_point_prevalence_average_value : 6.4 AND has_point_prevalence_range : 1-9 / 100 000 Kenya AND has_point_prevalence_average_value : 1.1 AND has_point_prevalence_range : 1-9 / 100 000 Ukraine AND has_point_prevalence_average_value : 0.35 AND has_point_prevalence_range : 1-9 / 1 000 000 Slovenia AND has_point_prevalence_average_value : 8.2 AND has_point_prevalence_range : 1-9 / 100 000 Latvia AND has_point_prevalence_average_value : 4.9 AND has_point_prevalence_range : 1-9 / 100 000 |
| treeView | |
| subClassOf |